Pretreatment differences in BOLD response to emotional faces correlate with Antidepress ant response to scopolamine

International Journal of Neuropsychopharmacology

Volumn 18, Issue 8, 2015, Pages 1-10

  Furey, Maura L ^a   Drevets, Wayne C ^b   Szczepanik, Joanna ^a   Khanna, Ashish ^c   Nugent, Allison ^a   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b JOHNSON AND JOHNSON   (United States)

^c BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

anticholinergic; antimuscarinic; Biomarker; mood disorders

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; SCOPOLAMINE; OXYGEN; SCOPOLAMINE BROMIDE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; EMOTION; FACE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MAJOR DEPRESSION; MALE; NERVE CELL; NEUROIMAGING; OCCIPITAL CORTEX; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; SELECTIVE ATTENTION; STIMULUS RESPONSE; TASK PERFORMANCE; TREATMENT RESPONSE; ATTENTION; BLOOD; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; FACIAL RECOGNITION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL RECOGNITION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PHOTIC STIMULATION; SCOPOLAMINE HYDROBROMIDE;

EID: 84931270575     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv028     Document Type: Article

References (65)

1. Bentley P, Vuilleumier P, Thiel CM, Driver J, Dolan RJ (2003) Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. NeuroImage 20:58-70.
2. Bradley BP, Mogg K, Williams R (1995) Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behav Res Ther 33:755-770.
3. Bradley BP, Mogg K, Millar N (1996) Implicit memory bias in clinical and non-clinical depression. Behav Res Ther 34:865-879.
4. Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ (2010) Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 30:16082-16090.
5. Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162-173.
6. Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003) The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160:64-75.
7. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-827.
8. Drevets WC, Furey ML (2010) Replication of scopolamines antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry 67:432-438.
9. Drevets WC, Zarate CA Jr, Furey ML (2012) Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry.
10. Dube S, Kumar N, Ettedgui E, Pohl R, Jones D, Sitaram N (1985) Cholinergic REM induction response: separation of anxiety and depression. Biol Psychiatry 20:408-418.
11. Ekman P, Friesen W V (1976) Pictures of Facial Affect. Palo Alto, CA:Consulting Psychologist Press
12. Erickson K, Drevets WC, Clark L, Cannon DM, Bain EE, Zarate CA Jr, Charney DS, Sahakian BJ (2005) Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Am J Psychiatry 162:2171-2173.
13. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV. Washington DC: American Psychiatric Press.
14. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61:877-889.
15. Furey ML (2011) The prominent role of stimulus processing: cholinergic function and dysfunction in cognition. Curr Opin Neurol 24:364-370.
16. Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121-1129.
17. Furey ML, Nugent AC, Speer AM, Luckenbaugh DA, Hoffman EM, Frankel E, Drevets WC, Zarate CA Jr (2012) Baseline moodstate measures as predictors of antidepressant response to scopolamine. Psychiatry Res 196:62-67.
18. Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA Jr (2013) Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry 70:280-290.
19. Gershon AA, Dannon PN, Grunhaus L (2003) Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 160:835-845.
20. Gorwood P, Bayle F, Vaiva G, Courtet P, Corruble E, Llorca PM (2013) Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysis. Eur Psychiatry 28:362-371.
21. Gotlib IH, Krasnoperova E, Yue DN, Joormann J (2004) Attentional biases for negative interpersonal stimuli in clinical depression. J Abnorm Psychol 113:121-135.
22. Harmer CJ (2008) Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55:1023-1028.
23. Insel TR, Wang PS (2009) The STAR D trial: revealing the need for better treatments. Psychiatric Services 60:1466-1467.
24. Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ (1972a) A cholinergic- adrenergic hypothesis of mania and depression. Lancet 2:632-635.
25. Janowsky DS, el-Yousef MK, Davis JM, Hubbard B, Sekerke HJ (1972b) Cholinergic reversal of manic symptoms. Lancet 1:1236-1237.
26. Janowsky DS, Overstreet DH, Nurnberger JI Jr (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54:335-344.
27. Keedwell P, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M (2009) Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J Psychopharmacol 23:775-788.
28. Keedwell PA, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M (2010) Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J Affect Disord 120:120-125.
29. Khan A, Khan SR, Shankles EB, Polissar NL (2002) Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol 17:281-285.
30. Kirschen MP, Chen SH, Schraedley-Desmond P, Desmond JE (2005) Load- and practice-dependent increases in cerebrocerebellar activation in verbal working memory: an fMRI study. NeuroImage 24:462-472.
31. Korb AS, Hunter AM, Cook IA, Leuchter AF (2009) Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol 120:1313-1319.
32. Koster EH, De Raedt R, Leyman L, De Lissnyder E (2010) Moodcongruent attention and memory bias in dysphoria: exploring the coherence among information-processing biases. Behav Res Ther 48:219-225.
33. Laxton AW, Neimat JS, Davis KD, Womelsdorf T, Hutchison WD, Dostrovsky JO, Hamani C, Mayberg HS, Lozano AM (2013) Neuronal coding of implicit emotion categories in the subcallosal cortex in patients with depression. Biological psychiatry 74:714-719.
34. Lee TW, Wu YT, Yu YW, Chen MC, Chen TJ (2011) The implication of functional connectivity strength in predicting treatment response of major depressive disorder: a resting EEG study. Psychiatry Res 194:372-377.
35. Lundqvist D, Flykt A, Ohman A (1998) The Karolinska Directed Emotional Faces- KDEF, CD ROM. In: (Department of Clinical Neuroscience PS, Karolinska Institute, ed).
36. MacQueen GM (2009) Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J Psychiatry Neurosci 34:343-349.
37. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997) Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8:1057-1061.
38. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. The Am J Psychiatry 156:675-682.
39. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651-660.
40. Miki A, Raz J, Englander SA, Butler NS, van Erp TG, Haselgrove JC, Liu GT (2001) Reproducibility of visual activation in functional magnetic resonance imaging at very high field strength (4 Tesla). Jpn J Ophthalmol 45:1-4.
41. Mogg K, Bradley BP, Williams R (1995) Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychol 34 (Pt 1):17-36.
42. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999) Emotional bias and inhibitory control processes in mania and depression. Psychological medicine 29:1307-1321.
43. Nierenberg AA, DeCecco LM (2001) Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment- resistant depression. J Clin Psychiatry 62:5-9.
44. Ongur D, Ferry AT, Price JL (2003) Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460:425-449.
45. Pizzagalli DA (2011) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36:183-206.
46. Price JL, Drevets WC (2010) Neurocircuitry of mood disorders. Neuropsychopharmacology 35:192-216.
47. Qin Y, Sohn MH, Anderson JR, Stenger VA, Fissell K, Goode A, Carter CS (2003) Predicting the practice effects on the blood oxygenation level-dependent (BOLD) function of fMRI in a symbolic manipulation task. Proc Natl Acad Sci 100:4951-4956.
48. Rombouts SA, Barkhof F, Hoogenraad FG, Sprenger M, Scheltens P (1998) Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging. Magn Reson Imaging 16:105-113.
49. Safer DJ, Allen RP (1971) The central effects of scopolamine in man. Biol Psychiatry 3:347-355.
50. Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CA Jr, Manji HK (2009) Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 65:289-295.
51. Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, Drevets WC, Zarate CA Jr (2010) Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology 35:1415-1422.
52. Sarter M, Hasselmo ME, Bruno JP, Givens B (2005) Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 48:98-111.
53. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001) Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50:651-658.
54. Siegle GJ, Carter CS, Thase ME (2006) Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163:735-738.
55. Siegle GJ, Thompson WK, Collier A, Berman SR, Feldmiller J, Thase ME, Friedman ES (2012) Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch Gen Psychiatry 69:913-924.
56. Simon GE, Perlis RH (2010) Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 167:1445-1455.
57. Sitaram N, Nurnberger JI Jr, Gershon ES, Gillin JC (1982) Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder. Am J Psychiatry 139:571-576.
58. Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, Williams SC, Phillips ML (2005) A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57:201-209.
59. Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME (2009) Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 70:344-353.
60. Talairach J, Tournoux P (1998) Coplanar stereotaxic atlas of the human brain. New York: Thieme Medical Publisher.
61. Tegeler C, Strother SC, Anderson JR, Kim SG (1999) Reproducibility of BOLD-based functional MRI obtained at 4 T. Hum Brain Mapp 7:267-283.
62. Victor TA, Furey ML, Fromm SJ, Ohman A, Drevets WC (2010) Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry 67:1128-1138.
63. Victor TA, Furey ML, Fromm SJ, Bellgowan PS, Ohman A, Drevets WC (2012) The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder. PLoS One 7:e46439.
64. Weigelt S, Muckli L, Kohler A (2008) Functional magnetic resonance adaptation in visual neuroscience. Rev Neurosci 19:363-30.
65. Zarate CA Jr, Mathews DC, Furey ML (2013) Human biomarkers of rapid antidepressant effects. Biol Psychiatry 73:1142-155.